Singapore: A Country Punching Above Its Weight
In an in-depth feature story about the innovation ecosystem that is thriving in Singapore, In Vivo reporter, David Wild spotlights Albatroz’s work to develop a platform to target tumor tissue growth and arthritic disorders that depend on extracellular matrix remodeling, big pharma recognition of the value being created and the leadership perspectives of Albatroz’s Chief Business Officer, Guy Heathers.
Excepts include:
- “Research is necessary, but you need people to take those ideas and develop them,” (Guy Heathers) told In Vivo
- Amgen has created the Golden Ticket award…The inaugural award was handed to Albatroz Therapeutics, which has developed a platform to target tumor tissue growth and arthritic disorders that depend on extracellular matrix remodeling. Heathers said it represents “big pharma recognition that we can create assets of value.”
#Biotech #Singapore #Innovation
Click the button below to read the full story.
(This article is subscriber-only, but interested parties can sign up for a free trial on the In Vivo Pharma Intelligence website.)